A price on health

摘要

THE vast majority of people in the UK support National Health Service treatments for rare diseases. But would that still hold true if treatments for cancer or hip and knee surgery were to be rationed on a regular basis? As the NHS winter crisis deepens, it would appear that with increasing longevity and complexity of medical conditions the economic burden on health and social care has no limit. So such questions arise.